2017-17871. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Ila S. Mizrachi, FDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

    Table 1—List of Information Collections Approved by OMB

    Title of collectionOMB control No.Date approval expires
    Premarket Notification Submission 510(k), Subpart E0910-01206/30/2020
    Institutional Review Boards0910-01306/30/2020
    Patent Term Restoration, Due Diligence Petitions, Filing, Format, and Content of Petitions0910-02336/30/2020
    Adverse Event Program for Medical Devices (Medical Product Safety Network (MedSun))0910-04716/30/2020
    Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products0910-05436/30/2020
    Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act0910-06796/30/2020
    Guidance for Industry: Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components Intended for Transfusion0910-06816/30/2020
    Providing Information About Pediatric Uses of Medical Devices Under Section 515A of the Federal Food, Drug, and Cosmetic Act0910-07626/30/2020
    Certification of Identity for Freedom of Information Act and Privacy Act Requests0910-08326/30/2020
    FDA Advisory Committee Membership Nominations0910-08336/30/2020
    Start Signature

    Dated: August 18, 2017.

    Leslie Kux,

    Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2017-17871 Filed 8-22-17; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
08/23/2017
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2017-17871
Pages:
40009-40009 (1 pages)
Docket Numbers:
Docket Nos. FDA-2013-N-0804, FDA-2013-N-1163, FDA-2013-N-1393, FDA-2017-N-0084, FDA-2013-N-0731, FDA-2009-D-0008, FDA-2013-N-0868, FDA-2013-D-0117, FDA-2016-N-2066, FDA-2017-N-0366
PDF File:
2017-17871.pdf